CN112263767A - Control method of insomnia therapeutic apparatus - Google Patents

Control method of insomnia therapeutic apparatus Download PDF

Info

Publication number
CN112263767A
CN112263767A CN202011130700.4A CN202011130700A CN112263767A CN 112263767 A CN112263767 A CN 112263767A CN 202011130700 A CN202011130700 A CN 202011130700A CN 112263767 A CN112263767 A CN 112263767A
Authority
CN
China
Prior art keywords
signal
wave signal
processor
user
brain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202011130700.4A
Other languages
Chinese (zh)
Other versions
CN112263767B (en
Inventor
陈南西
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chongqing Fitness Technology Co ltd
Original Assignee
Chongqing Fitness Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chongqing Fitness Technology Co ltd filed Critical Chongqing Fitness Technology Co ltd
Priority to CN202011130700.4A priority Critical patent/CN112263767B/en
Publication of CN112263767A publication Critical patent/CN112263767A/en
Application granted granted Critical
Publication of CN112263767B publication Critical patent/CN112263767B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
    • A61M21/02—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis for inducing sleep or relaxation, e.g. by direct nerve stimulation, hypnosis, analgesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4806—Sleep evaluation
    • A61B5/4809—Sleep detection, i.e. determining whether a subject is asleep or not
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4806—Sleep evaluation
    • A61B5/4812—Detecting sleep stages or cycles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4806—Sleep evaluation
    • A61B5/4815—Sleep quality
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014—External stimulators, e.g. with patch electrodes
    • A61N1/36025—External stimulators, e.g. with patch electrodes for treating a mental or cerebral condition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014—External stimulators, e.g. with patch electrodes
    • A61N1/3603—Control systems
    • A61N1/36031—Control systems using physiological parameters for adjustment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
    • A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
    • A61M2021/0055—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus with electric or electro-magnetic fields
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/08—Other bio-electrical signals
    • A61M2230/10—Electroencephalographic signals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P90/00—Enabling technologies with a potential contribution to greenhouse gas [GHG] emissions mitigation
    • Y02P90/02—Total factory control, e.g. smart factories, flexible manufacturing systems [FMS] or integrated manufacturing systems [IMS]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Anesthesiology (AREA)
  • Medical Informatics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Psychology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Developmental Disabilities (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Social Psychology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Physiology (AREA)
  • Pain & Pain Management (AREA)
  • Acoustics & Sound (AREA)
  • Hematology (AREA)
  • Electrotherapy Devices (AREA)

Abstract

The invention discloses a control method of an insomnia therapeutic apparatus, which comprises the following steps: the first processor collects brain wave signals of a user, judges whether the brain wave signal type of the user belongs to beta wave signals, and if so, the first processor generates the beta wave signals which are superposed on the brain stimulation modulation wave signals and sent to the composite electrode plate unit; the first processor judges whether the brain wave signal type of the user belongs to an alpha wave signal, and if so, the first processor generates an alpha wave signal which is superposed on the brain stimulation modulation wave signal and sent to the composite electrode plate unit; the first processor judges whether the brain wave signal type of the user belongs to a theta wave signal, and if so, the first processor generates an alpha wave signal, superposes the theta wave signal in the same frequency domain, superposes the theta wave signal on the brain stimulation modulation wave signal, and sends the superposed theta wave signal to the composite electrode plate unit. The invention generates a composite treatment electric shock signal to stimulate the brain according to the brain stimulation modulation wave signal and the brain wave signal of the brain of the user, thereby improving the insomnia condition of the user.

Description

Control method of insomnia therapeutic apparatus
Technical Field
The invention relates to the technical field of medical equipment, in particular to a control method of an insomnia therapeutic apparatus.
Background
In modern society, as the society rhythm is fast, the working pressure is too big, and a lot of people easily suffer from insomnia, and the work and the life of people are seriously influenced by long-term insomnia and poor sleep, so that the working efficiency of people is reduced, and the life quality is reduced.
In the prior art, insomnia is mostly treated by adopting medicines, the medicines have large side effects, and the physical and psychological health of people is easily influenced after long-term administration.
For patients suffering from insomnia, the patients often can not sleep at night and have poor energy and want to sleep in the daytime.
The prior art has the defects that the existing control method of the insomnia therapeutic apparatus mostly applies an electric shock signal with fixed frequency and amplitude to the brain of a user to electrically stimulate the brain of the user so as to promote the improvement of the sleep of the user, and cannot generate a composite treatment electric shock signal to stimulate the brain of the user according to the brain stimulation modulation wave signal and the brain wave signal of the brain of the user so as to improve the sleep condition of the user.
Disclosure of Invention
In view of at least one of the drawbacks of the prior art, it is an object of the present invention to provide a control method of an insomnia treatment apparatus for stimulating a user's brain by generating a composite therapeutic shock signal based on a brain stimulation modulation wave signal and a brain wave signal of the user's brain to improve the user's insomnia condition.
In order to achieve the purpose, the invention adopts the following technical scheme: a control method of an insomnia therapeutic apparatus is used for the insomnia therapeutic apparatus, the insomnia therapeutic apparatus comprises a first processor, the first processor is connected with a user brain wave acquisition module, and the first processor acquires brain wave signals of a user through the user brain wave acquisition module;
the first processor is also connected with a modulation wave generation module; the modulation wave generation module stores brain stimulation modulation wave data; the first processor is also provided with a signal output end group and is connected with the pulse control circuit through the signal output end group; the pulse control circuit is connected with a composite electrode plate unit;
the key point is that the method comprises the following steps:
step A: the first processor collects brain wave signals of a user through a user brain wave acquisition module and judges the type of the brain wave signals of the user;
determining the sleep/wake state of the user according to the brain wave signal type; the sleep/wake state mainly comprises a waking state, a pre-sleep state, a sleep state and a deep sleep state; the brain wave signal types comprise beta wave signals, alpha wave signals, theta wave signals and delta wave signals;
beta wave signal: the amplitude is generally lower, generally about 5uV, the frequency range is f & gt 13Hz and f is less than or equal to 30Hz, and the beta wave belongs to the fast wave in brain waves. The waveform occurs when a person is nervous, emotional, or excited.
α -wave signal: the amplitude is generally 20-75 uV, the frequency range is f & gt 8Hz and f & lt, 13Hz, alpha waves are relatively fast waves in brain waves and are basic waveforms of normal people, the alpha waves are most obvious when people are awake and close eyes, and the alpha waves disappear immediately after eyes are opened.
The theta wave signal: the amplitude is generally 20-150 uV, the frequency range is f & gt 4Hz and f is less than or equal to 8Hz, the slow wave belongs to slow waves, the waveform cannot be detected by normal people in a waking state, and the waveform can be observed only under the condition of drowsiness or light sleep.
The delta wave signal: the amplitude is generally 20-200 uV, the frequency range is that f is more than or equal to 1Hz and less than or equal to 4Hz, the amplitude is the wave with the lowest frequency in the electroencephalogram signals, the normal person can not generate delta waves in the waking state, and the delta waves can only occur in the extreme fatigue or deep sleep state.
And B: the first processor judges whether the brain wave signal type of the user belongs to a beta wave signal, and if so, the step C is carried out; otherwise, entering the step D;
determining the type of the sleep/wake state of the user as a wake state when the user belongs to a beta wave signal;
and C: the first processor generates a beta wave signal to the pulse control circuit, the pulse control circuit superposes the beta wave signal on the brain stimulation modulation wave signal to generate a composite treatment electric shock signal a which is sent to the composite electrode plate unit to induce the release and enhancement of the electroencephalogram beta signal, so that the degree of an awake state of a user is kept and improved; returning to the step A;
preferably, the first processor can delay N seconds and return to the step A, and the N seconds are 10-30 seconds; the finger delays for 10-30 seconds to collect data again, so that the collection frequency of the brain wave acquisition module can be reduced.
Step D: the first processor judges whether the brain wave signal type of the user belongs to an alpha wave signal, if so, the step E is carried out; otherwise, entering step F;
if the signal belongs to the alpha wave signal, determining that the sleep/wake state type of the user is in the early stage of falling asleep;
step E: the first processor generates an alpha wave signal to the pulse control circuit, and the pulse control circuit superposes the alpha wave signal on the brain stimulation modulation wave signal to generate a composite treatment electric shock signal b and sends the composite treatment electric shock signal b to the composite electrode plate unit; the release and enhancement of the EEG alpha signal are induced, and the sleep is promoted; returning to the step A;
preferably, the first processor can delay N seconds and return to the step A, and the N seconds are 10-30 seconds;
step F: the first processor judges whether the brain wave signal type of the user belongs to a theta wave signal, if so, the first processor generates an alpha wave signal, superposes the theta wave signal in the same frequency domain and sends the theta wave signal to the pulse control circuit, and the pulse control circuit superposes the alpha wave signal and the theta wave signal on the brain stimulation modulation wave signal to generate a composite treatment electric shock signal c which is sent to the composite electrode plate unit; maintaining a sleep state; returning to the step A; otherwise, entering step G;
determining the type of the sleep/wake-up state to be in a sleep state if the signal belongs to the theta wave signal;
preferably, the first processor can delay N seconds and return to the step A, and the N seconds are 10-30 seconds;
step G: the first processor judges whether the brain wave signal type of the user belongs to a delta wave signal, if so, the first processor stops outputting signals to the pulse control circuit, stops thalamic stimulation, maintains a deep sleep state, and returns to the step A; otherwise, returning to the step A.
The signal belonging to the delta wave determines that the sleep/wake state type of the user is in a deep sleep state.
Through the control method, the first processor generates a composite treatment electric shock signal according to the brain stimulation modulation wave signal and the brain wave signal of the brain of the user to stimulate the brain of the user, so that the insomnia condition of the user is improved.
The control method of the insomnia therapeutic apparatus is characterized in that: the first processor collects brain wave signals of a user through a brain wave acquisition module of the user and judges the type of the brain wave signals of the user, wherein the first processor comprises the following steps;
step A11: the first processor acquires brain wave signals of a user through a user brain wave acquisition module;
step A12: the first processor performs FFT frequency domain change on the brain wave signals;
step A13: the first processor acquires the frequency f of the brain wave signal of the user by adopting a brain wave acquisition algorithm, the frequency of the brain wave signal is represented by f, and the type of the brain wave signal of the user is judged according to the frequency f of the brain wave signal of the user.
The first processor collects brain wave signals of a user through a user brain wave acquisition module and carries out FFT Fourier frequency domain change on the brain wave signals; and then acquiring the brain wave signal frequency f of the user through a brain wave acquisition algorithm.
The control method of the insomnia therapeutic apparatus is characterized in that: the judging the type of the brain wave signal of the user according to the brain wave signal frequency f of the user comprises:
if f is more than 13Hz and f is less than or equal to 30Hz, judging that the brain wave signal of the user belongs to a beta wave signal, and judging that the sleep/wake state of the user is a waking state;
if f is more than 8Hz and f is less than or equal to 13Hz, judging that the brain wave signal of the user belongs to an alpha wave signal, and judging that the sleep/wake state of the user is in the early stage of falling asleep;
if f is more than 4Hz and f is less than or equal to 8Hz, judging that the brain wave signal of the user belongs to the theta wave signal, and judging that the sleep/wake state of the user is in the sleep state;
if f is more than or equal to 1Hz and f is less than or equal to 4Hz, the brain wave signal of the user is judged to belong to a delta wave signal, and the sleep/wake state of the user is judged to be a deep sleep state.
The type of the brain wave signal of the user can be determined by the range of the brain wave frequency f.
The control method of the insomnia therapeutic apparatus is characterized in that: the electroencephalogram acquisition algorithm adopts a nonlinear dynamics method to calculate the sample entropy of the electroencephalogram signals of the user, and the frequency f of the electroencephalogram signals is obtained according to the sample entropy.
The first processor is connected with the modulation wave generation module, the modulation wave generation module is connected with the first control end group of the pulse control circuit, and the first processor sends a brain stimulation modulation wave signal to the pulse control circuit;
the first processor is also provided with a signal output end group which is connected with a second control end group of the pulse control circuit and sends brain wave signals to the pulse control circuit.
The modulation wave generation module stores brain stimulation modulation wave data, and the first processor acquires brain wave signals of a user through the user brain wave acquisition module; generating a brain wave stimulation signal according to the brain wave signal, and superposing the brain wave stimulation signal on a brain stimulation modulation wave signal to generate a composite treatment electric shock signal to the composite electrode plate unit; the composite electrode plate unit applies a composite treatment electric shock signal to the brain of the user to treat insomnia.
The first processor generates a brain wave signal which is superposed on the brain stimulation modulation wave through the pulse control circuit to obtain a composite treatment electric shock signal.
The brain wave signals include alpha wave signals, theta wave signals, and beta wave signals.
The composite electrode plate unit comprises at least one composite electrode plate.
If two composite electrode plates are provided, which are respectively arranged at both sides of the brain, a composite therapeutic shock signal in a forward direction or a reverse direction can be applied through the two composite electrode plates.
The user brain wave acquisition module comprises a second processor, the second processor is in wired/wireless connection with the first processor, the second processor is connected with an acquisition module, the acquisition module is connected with an acquisition electrode plate and/or composite electrode plate unit, and the second processor acquires brain wave signals of a user through the acquisition electrode plate and/or composite electrode plate unit.
The composite electrode plate of the composite electrode plate unit can be used for acquiring brain wave signals of a user and applying composite treatment electric shock signals to the brain of the user; when the first processor needs to collect brain wave signals of a user, the pulse control circuit is controlled to stop working, the composite treatment electric shock signals are stopped being applied to the composite electrode plate, the first processor sends instructions to the second processor, and the second processor is connected with the composite electrode plate unit through the collection module to collect the brain wave signals of the user; the second processor sends the brain wave signals of the user to the first processor for storage; when the first processor does not need to collect the brain wave signals of the user, the first processor sends an instruction to the second processor to stop collecting the brain wave signals of the user, control the pulse control circuit to work and apply composite treatment electric shock signals to the composite electrode plate.
The collecting electrode plate is specially used for obtaining brain wave signals of a user, and the user can select the collecting electrode plate, the composite electrode plate unit or the combination of the collecting electrode plate and the composite electrode plate unit according to needs. The collecting electrode plate needs to be specially added with the electrode plate, and the number of the electrode plates can be reduced by adopting the composite electrode plate unit.
The modulation wave generation module comprises an analog signal generation module, and the analog signal generation module is connected with a Flash memory and an analog amplifier circuit; the first processor is connected with the analog amplifier circuit through the inverter circuit; the analog amplifier circuit is connected with the pulse control circuit;
the Flash memory stores brain stimulation modulation wave data; the analog signal generating module acquires brain stimulation modulation wave data of the Flash memory to generate a brain stimulation modulation wave signal to the analog amplifier circuit, and the analog amplifier circuit outputs the amplified brain stimulation modulation wave signal to the pulse control circuit.
The Flash memory stores brain stimulation modulation wave data; the data is stored in a digital signal mode, and the analog signal generating module converts the digital signal into an analog signal which is amplified by an analog amplifier circuit and then converted into a brain stimulation modulation wave signal to a pulse control circuit. The first processor is connected with the analog amplifier circuit through the inverter circuit to control the operation of the analog amplifier circuit, such as controlling the analog amplifier circuit to send out signals or stopping sending out signals.
The first processor is also connected with the analog amplifier circuit through a digital potentiometer; the output signal of the analog amplifier circuit is regulated.
Through the structural arrangement, the output signal of the analog amplifier circuit can be adjusted.
The invention has the obvious effect that the invention provides a control method of the insomnia therapeutic apparatus, which generates a composite treatment electric shock signal to stimulate the brain of a user according to the brain stimulation modulation wave signal and the brain wave signal of the brain of the user, thereby improving the insomnia condition of the user.
Drawings
FIG. 1 is a block diagram of a circuit module according to the present invention;
FIG. 2 is a circuit diagram of a second processor;
FIG. 3 is a circuit diagram of an acquisition module;
FIG. 4 is a circuit diagram of an acquisition interface circuit;
FIG. 5 is a circuit diagram of a second power module;
FIG. 6 is a circuit diagram of a first processor;
FIG. 7 is a circuit diagram of a pulse control circuit;
FIG. 8 is a circuit diagram of a Flash memory;
FIG. 9 is a circuit diagram of an analog signal generating module;
FIG. 10 is a circuit diagram of an analog amplifier circuit and a digital potentiometer;
FIG. 11 is a circuit diagram of an inverter circuit;
FIG. 12 is a circuit diagram of a boost controller circuit;
FIG. 13 is a circuit diagram of a first power module;
fig. 14 is a waveform diagram of a user's brain wave signal;
FIG. 15 is a waveform diagram of a composite therapeutic shock signal;
FIG. 16 is a flow chart of a method of the present invention.
Detailed Description
The invention is described in further detail below with reference to the figures and specific examples.
As shown in fig. 1 to 16, a control method of an insomnia treatment apparatus is used for the insomnia treatment apparatus, the insomnia treatment apparatus includes a first processor 1, the first processor 1 is connected with a user brain wave acquisition module 2, and the first processor 1 acquires brain wave signals of the user through the user brain wave acquisition module 2;
the first processor 1 is also connected with a modulation wave generation module 3; the modulation wave generation module 3 stores brain stimulation modulation wave data; the modulation wave generation module 3 is connected with a pulse control circuit 4, the first processor 1 controls the modulation wave generation module 3 to send out a brain stimulation modulation wave signal to the pulse control circuit 4, the first processor 1 is also provided with a signal output end group, and the first processor 1 is connected with the pulse control circuit 4 through the signal output end group; the pulse control circuit 4 is connected with a composite electrode plate unit 5;
as shown in fig. 16, the key point is that the method comprises the following steps:
step A: the first processor 1 collects the brain wave signals of the user through the brain wave acquisition module 2 of the user and judges the type of the brain wave signals of the user;
determining the sleep/wake state of the user according to the brain wave signal type; the sleep/wake state mainly comprises a waking state, a pre-sleep state, a sleep state and a deep sleep state; the brain wave signal types comprise beta wave signals, alpha wave signals, theta wave signals and delta wave signals;
beta wave signal: the amplitude is generally lower, generally about 5uV, the frequency range is f & gt 13Hz and f is less than or equal to 30Hz, and the beta wave belongs to the fast wave in brain waves. The waveform occurs when a person is nervous, emotional, or excited.
α -wave signal: the amplitude is generally 20-75 uV, the frequency range is f & gt 8Hz and f & lt, 13Hz, alpha waves are relatively fast waves in brain waves and are basic waveforms of normal people, the alpha waves are most obvious when people are awake and close eyes, and the alpha waves disappear immediately after eyes are opened.
The theta wave signal: the amplitude is generally 20-150 uV, the frequency range is f & gt 4Hz and f is less than or equal to 8Hz, the slow wave belongs to slow waves, the waveform cannot be detected by normal people in a waking state, and the waveform can be observed only under the condition of drowsiness or light sleep.
The delta wave signal: the amplitude is generally 20-200 uV, the frequency range is that f is more than or equal to 1Hz and less than or equal to 4Hz, the amplitude is the wave with the lowest frequency in the electroencephalogram signals, the normal person can not generate delta waves in the waking state, and the delta waves can only occur in the extreme fatigue or deep sleep state.
And B: the first processor 1 judges whether the brain wave signal type of the user belongs to a beta wave signal, if so, the step C is carried out; otherwise, entering the step D;
determining the type of the sleep/wake state of the user as a wake state when the user belongs to a beta wave signal;
and C: the first processor 1 generates a beta wave signal to the pulse control circuit 4, the pulse control circuit 4 superposes the beta wave signal on the brain stimulation modulation wave signal to generate a composite treatment electric shock signal a, the composite treatment electric shock signal a is sent to the composite electrode plate unit 5, the release and the enhancement of the electroencephalogram beta signal are induced, and the degree of an awake state of a user is kept and improved; returning to the step A;
when the user needs to keep awake, the user can keep awake by increasing the beta wave stimulation signal;
step D: the first processor 1 judges whether the brain wave signal type of the user belongs to an alpha wave signal, if so, the step E is carried out; otherwise, entering step F;
if the signal belongs to the alpha wave signal, determining that the sleep/wake state type of the user is in the early stage of falling asleep;
step E: the first processor 1 generates an alpha wave signal to the pulse control circuit 4, the pulse control circuit 4 superposes the alpha wave signal on the brain stimulation modulation wave signal to generate a composite treatment electric shock signal b, and the composite treatment electric shock signal b is sent to the composite electrode plate unit 5; the release and enhancement of the EEG alpha signal are induced, and the sleep is promoted; returning to the step A;
step F: the first processor 1 judges whether the brain wave signal type of the user belongs to a theta wave signal, if so, the first processor 1 generates an alpha wave signal, superposes the theta wave signal in the same frequency domain and sends the theta wave signal to the pulse control circuit 4, and the pulse control circuit 4 superposes the alpha wave signal and the theta wave signal on a brain stimulation modulation wave signal to generate a composite treatment electric shock signal c and sends the composite treatment electric shock signal c to the composite electrode plate unit 5; maintaining a sleep state; returning to the step A; otherwise, entering step G;
determining the type of the sleep/wake-up state to be in a sleep state if the signal belongs to the theta wave signal;
step G: the first processor 1 judges whether the brain wave signal type of the user belongs to a delta wave signal, if so, the first processor 1 stops outputting signals to the pulse control circuit 4, stops thalamic stimulation, maintains a deep sleep state, and returns to the step A; otherwise, returning to the step A.
Belonging to the delta wave signal determining the type of sleep/wake state of the user in a deep sleep state, the first processor 1 stops outputting a signal, which is either a beta wave signal or an alpha wave signal or a theta wave signal, to the pulse control circuit 4.
Through the control method, the first processor 1 generates a composite treatment electric shock signal according to the brain stimulation modulation wave signal and the brain wave signal of the brain of the user to stimulate the brain of the user, so that the insomnia condition of the user is improved.
The control method of the insomnia therapeutic apparatus is characterized in that: the first processor 1 collects the brain wave signals of the user through the brain wave acquisition module 2 of the user, and the step of judging the types of the brain wave signals of the user comprises the following steps;
step A11: the first processor 1 collects brain wave signals of a user through a brain wave acquisition module 2 of the user;
step A12: the first processor 1 performs FFT frequency domain change on the brain wave signals;
step A13: the first processor 1 acquires the brain wave signal frequency f of the user by adopting a brain wave acquisition algorithm, the brain wave signal frequency is represented by f, and the brain wave signal type of the user is judged according to the brain wave signal frequency f of the user. The first processor 1 collects the brain wave signal of the user through the brain wave acquisition module 2 of the user, and performs FFT Fourier frequency domain change on the brain wave signal; and then acquiring the brain wave signal frequency f of the user through a brain wave acquisition algorithm.
The control method of the insomnia therapeutic apparatus is characterized in that: the judging the type of the brain wave signal of the user according to the brain wave signal frequency f of the user comprises:
if f is more than 13Hz and f is less than or equal to 30Hz, judging that the brain wave signal of the user belongs to a beta wave signal, and judging that the sleep/wake state of the user is a waking state; if f is more than 8Hz and f is less than or equal to 13Hz, judging that the brain wave signal of the user belongs to an alpha wave signal, and judging that the sleep/wake state of the user is in the early stage of falling asleep; if f is more than 4Hz and f is less than or equal to 8Hz, judging that the brain wave signal of the user belongs to the theta wave signal, and judging that the sleep/wake state of the user is in the sleep state; if f is more than or equal to 1Hz and f is less than or equal to 4Hz, the brain wave signal of the user is judged to belong to a delta wave signal, and the sleep/wake state of the user is judged to be a deep sleep state.
The type of the brain wave signal of the user can be determined by the range of the brain wave frequency f.
The control method of the insomnia therapeutic apparatus is characterized in that: the electroencephalogram acquisition algorithm adopts a nonlinear dynamics method to calculate the sample entropy of the electroencephalogram signals of the user, and the frequency f of the electroencephalogram signals is obtained according to the sample entropy. The control method of the insomnia therapeutic apparatus is characterized in that: the nonlinear dynamical method comprises the following steps:
firstly, a first processor (1) collects N brain wave signals, and the N brain wave signals are represented by u; u ═ u (1), u (2), … …, u (a), … …, u (n); u (a) represents one of the brain wave signals;
② construct a set of m-dimensional vectors, Xm(1)，Xm(2)，……，Xm(i),……，Xm(N) specifying Xm(i)＝{u(i+k)}，0≤k≤m-1；
③ the distance between any two unequal vectors in the m-dimensional vectors is defined as:
d[Xm(i)，Xm(j)]max { | u (i + k-u (i + k)) | }, 1 ≦ i ≦ N; j is more than or equal to 1 and less than or equal to N; and i is not equal to j;
setting a threshold r and then calculating each vector Xm(i) Distance d [ X ] between value and remaining vectorm(i)，Xm(j)]Where SD is the standard deviation of the sequence and the ratio to the total number of distances is taken as:
Figure BDA0002735046150000121
this is Xm(i) Template pieceThe preparation process comprises the following steps of (1),
Figure BDA0002735046150000122
represents any one of Xm(j) Probability of matching with a template;
fifthly, obtain
Figure BDA0002735046150000123
The average of (d) is recorded as:
Figure BDA0002735046150000124
increasing the dimension number to m +1 to form a m + 1-dimensional vector,
Xm+1(1)，Xm+1(2)，……，Xm+1(i),……，Xm+1(N)，
and specifies Xm+1(i)＝{u(i+k)}，0≤k≤m；
Repeating the operation of the third to the fifth steps on the m +1 dimensional vector to obtain Cm+1(r)；
The formula for calculating the sample entropy is:
Figure BDA0002735046150000125
so when N is 4000, the formula for calculating the sample entropy when r is 0.2 is:
SampEn(m,r,N)＝-ln[Cm+1(r)/Cm(r)] (4)
the sample entropy is taken as the brain wave signal frequency f.
The first processor 1 is connected with a modulation wave generation module 3, the modulation wave generation module 3 is connected with a first control end group of the pulse control circuit 4, and a brain stimulation modulation wave signal is sent to the pulse control circuit 4;
the first processor 1 is further provided with a signal output terminal group, and the signal output terminal group is connected with the second control terminal group of the pulse control circuit 4 and sends brain wave signals to the pulse control circuit 4.
The modulated wave generating module 3 stores brain stimulation modulated wave data, and the first processor 1 acquires brain wave signals of a user through the user brain wave acquiring module 2; generating a brain wave stimulation signal according to the brain wave signal, and superposing the brain wave stimulation signal on a brain stimulation modulation wave signal to generate a composite treatment electric shock signal to the composite electrode plate unit 5; the composite electrode plate unit 5 applies a composite treatment electric shock signal to the brain of the user to treat insomnia.
The first processor 1 generates a brain wave signal which is superimposed on the brain stimulation modulation wave through the pulse control circuit 4 to obtain a composite treatment shock signal.
The brain wave signals include alpha wave signals, theta wave signals, and beta wave signals.
The composite electrode plate unit 5 includes at least one composite electrode plate.
If two composite electrode plates are provided, which are respectively arranged at both sides of the brain, a composite therapeutic shock signal in a forward direction or a reverse direction can be applied through the two composite electrode plates.
Such as from left to right or from right to left.
As shown in fig. 6 and 7, the first processor 1 adopts a C8051 single chip microcomputer, the first processor 1 is connected to the modulated WAVE generating module 3, the modulated WAVE generating module 3 is connected to a first control end group of the pulse control circuit 4, that is, a control end sent _ WAVE and a control end WAVE, and sends a brain stimulation modulated WAVE signal to the pulse control circuit 4;
the first processor 1 is further connected to the control terminal K01, the control terminal K02, the control terminal K03 and the control terminal K04 of the second control terminal group of the pulse control circuit 4 through the pin P1.3, the pin P1.4, the pin P1.5 and the pin P1.6, respectively, to send brain wave signals to the pulse control circuit 4.
The user brain wave acquisition module 2 comprises a second processor 21, the second processor 21 is in wired/wireless connection with the first processor 1, the second processor 21 is connected with an acquisition module 22, the acquisition module 22 is connected with an acquisition electrode plate 23 and/or a composite electrode plate unit 5, and the second processor 21 acquires brain wave signals of a user through the acquisition electrode plate 23 and/or the composite electrode plate unit 5.
With reference to fig. 1 to fig. 4, the second processor 21 employs an msp430f5528 single-chip microcomputer, and the msp430f5528 single-chip microcomputer can output data to the first processor 1 through a serial port; the acquisition module 22 employs an ADS1299 acquisition module.
The acquisition module 22 is connected with the acquisition electrode plate 23 and the composite electrode plate unit 5 through an acquisition interface circuit; the composite electrode plate unit 5 comprises a composite electrode plate DJ01 and a composite electrode plate DJ 02;
the acquisition module 22 adopts an ADS1299 acquisition module, the acquisition interface circuit comprises a first interface circuit and a second interface circuit, the first interface circuit comprises a capacitor C13, a capacitor C12, a capacitor C8 and a capacitor C9, and one end of the capacitor C13 is connected with a signal acquisition terminal AIN1_ P of the acquisition module 22; the other end of the capacitor C13 is grounded, and a signal acquisition end AIN1_ P is connected with the composite electrode plate DJ01 through a resistor R12;
one end of the capacitor C12 is connected with the signal acquisition end AIN1_ N of the acquisition module 22; the other end of the capacitor C12 is grounded, and one end of the capacitor C12 is also connected with one end of the resistor R11;
one end of the capacitor C9 is connected to the signal acquisition end AIN2_ P of the acquisition module 22; the other end of the capacitor C9 is grounded, and a signal acquisition end AIN2_ P is connected with the composite electrode plate DJ02 through a resistor R9;
one end of the capacitor C8 is connected with the signal acquisition end AIN2_ N of the acquisition module 22; the other end of the capacitor C8 is grounded, one end of the capacitor C8 is also connected with one end of the resistor R6, and one end of the resistor R6 is connected with the other end of the resistor R11;
the second interface circuit comprises a capacitor C2, one end of the capacitor C2 is connected with a signal acquisition terminal AIN3_ P of the acquisition module 22; the other end of the capacitor C2 is grounded, and the signal acquisition end AIN3_ P is connected with the acquisition electrode plate 23 through a resistor R3.
The acquisition interface circuit can effectively acquire the brain wave signals of the user and eliminate interference.
With reference to fig. 5, a second power module is further included, and the second power module supplies power to the second processor 21 and the acquisition module 22.
The second power module is provided with a second lithium battery, the second lithium battery is connected with a charging interface P7 through a second charging management controller U5, the second lithium battery is connected with a second boost DC-DC converter U1, the second boost DC-DC converter U1 is connected with a second voltage stabilizing chip U11, the second voltage stabilizing chip U11 is connected with a first direct current 5V output chip U2 to output 5V direct current, the second voltage stabilizing chip U11 is connected with a second direct current 3.3V output chip U2 to output 3.3V direct current.
The composite electrode plate of the composite electrode plate unit 5 can be used for not only acquiring brain wave signals of a user, but also applying composite treatment electric shock signals to the brain of the user; when the first processor 1 needs to collect the brain wave signals of the user, the pulse control circuit 4 is controlled to stop working, the composite treatment electric shock signals are stopped being applied to the composite electrode plate, the first processor 1 sends instructions to the second processor 21, and the second processor 21 is connected with the composite electrode plate unit 5 through the collection module 22 to collect the brain wave signals of the user; the second processor 21 transmits the brain wave signals of the user to the first processor 1 for storage; when the first processor 1 does not need to collect the brain wave signals of the user, the first processor 1 sends an instruction to the second processor 21 to stop collecting the brain wave signals of the user, and controls the pulse control circuit 4 to work to apply the composite therapeutic shock signals to the composite electrode plate. The collecting electrode plate 23 is specially used for obtaining brain wave signals of a user, and the user can select the collecting electrode plate 23, the composite electrode plate unit 5 or a combination of the two according to needs. The acquisition electrode plate 23 is specially added with electrode plates, and the number of the electrode plates can be reduced by adopting the composite electrode plate unit 5.
The modulation wave generation module 3 comprises an analog signal generation module 31, and the analog signal generation module 31 is connected with a Flash memory 32 and an analog amplifier circuit 33; the first processor 1 is connected to the analog amplifier circuit 33 through the inverter circuit 34; the analog amplifier circuit 33 is connected to the pulse control circuit 4;
the Flash memory 31 stores brain stimulation modulated wave data; the analog signal generating module 32 obtains the brain stimulation modulation wave data of the Flash memory 31 to generate a brain stimulation modulation wave signal to the analog amplifier circuit 33, and the analog amplifier circuit 33 outputs the amplified brain stimulation modulation wave signal to the pulse control circuit 4.
The analog signal generating module 32 is connected to a reset circuit 311, and when the device is powered on, the reset circuit 311 resets the analog signal generating module 32, and the analog signal generating module 32 is reset.
As shown in fig. 1, 8, 9, 10, and 11, the analog signal generating module 32 employs a GBD502_ SOP16 module, and the reset circuit 311 employs a TCM809TENB713 module. The analog amplifier circuit 33 adopts an MCP6004-X/ST module, the digital potentiometer 35 adopts an MCP4017 module, and the inverter circuit 34 adopts a CD4069UB _ PW _14 module;
the Flash memory 31 is provided with a data output terminal WAVE _ CS which is connected with the analog signal generating module 32 through the data output terminal WAVE _ CS, and the analog signal generating module 32 is provided with a data output terminal WAVE which is connected with the analog amplifier circuit 33 through the data output terminal WAVE; the 8-pin and 9-pin of the analog amplifier circuit 33 are connected to the first control terminal group of the pulse control circuit 4, i.e., the control terminal sent _ WAVE and the control terminal WAVE, and send the brain stimulation modulated WAVE signal to the pulse control circuit 4.
The signal control terminal MCLK of the first processor 1 is connected to the inverter circuit 34, and the signal control terminal WAVE MOD of the inverter circuit 34 is connected to the analog amplifier circuit 33, so as to control the operation of the analog amplifier circuit 33.
The Flash memory 31 stores brain stimulation modulated wave data; the data is stored in the form of digital signals, and the analog signal generating module 31 converts the digital signals into analog signals, which are amplified by the analog amplifier circuit 33 and then converted into brain stimulation modulation wave signals to the pulse control circuit 4. The first processor 1 is connected to the analog amplifier circuit 33 through the inverter circuit 34 to control its operation, such as to control its emission or stop emission of a signal.
The first processor 1 is also connected with an analog amplifier circuit 33 through a digital potentiometer 35; the output signal of the analog amplifier circuit 33 is adjusted.
The control terminal SCL and the control terminal SDA of the first processor 1 are connected to the digital potentiometer 35, the pin 5 of the digital potentiometer 35 is connected to the pin 13 of the analog amplifier circuit 33, and the control terminal cut _ WAVE of the analog amplifier circuit 33 is connected to the common terminal of the resistors U5R2 and U5R 4.
With the above-described structural arrangement, the magnitude of the output signal of the analog amplifier circuit 33 can be adjusted.
The pulse control circuit 4 comprises a PNP triode Q2, a first optical coupler unit OPT1, a second optical coupler unit OPT3, a third optical coupler unit OPT4, a fourth optical coupler unit OPT5 and a fifth optical coupler unit OPT6, wherein an emitter of the PNP triode Q2 is connected with one end of a resistor Q2R1, the other end of the resistor Q2R1 is connected with an electric shock direct current power supply, the electric shock direct current power supply is also connected with a base electrode of the PNP triode Q2 through a resistor Q3R1, a collector electrode of a receiving triode of the first optical coupler unit OPT1 is connected with a base electrode of the PNP triode Q2, and an emitter electrode of the receiving triode of the first optical coupler unit OPT1 is grounded through a resistor Q3R 2; the light emitting diode of the first optical coupling unit OPT1 is connected with the analog amplifier circuit 33 to obtain a brain stimulation modulation wave signal;
a collector electrode of the PNP triode Q2 is connected with a collector electrode of the receiving triode of the second optocoupler unit OPT3, and a collector electrode of the receiving triode of the second optocoupler unit OPT3 is connected in parallel with a collector electrode of the receiving triode of the third optocoupler unit OPT 4; the composite electrode plate unit 5 comprises a composite electrode plate DJ01 and a composite electrode plate DJ 02; an emitter electrode of a receiving triode of the second optical coupling unit OPT3 is connected with the composite electrode plate DJ01, the composite electrode plate DJ01 is also connected with a collector electrode of a receiving triode of the fourth optical coupling unit OPT5, and an emitter electrode of the receiving triode of the fourth optical coupling unit OPT5 is grounded;
an emitter electrode of a receiving triode of the third optical coupling unit OPT4 is connected with the composite electrode plate DJ02, the composite electrode plate DJ02 is also connected with a collector electrode of a receiving triode of the fifth optical coupling unit OPT6, and an emitter electrode of the receiving triode of the fifth optical coupling unit OPT6 is grounded;
the light emitting diode of the second optical coupling unit OPT3, the light emitting diode of the third optical coupling unit OPT4, the light emitting diode of the fourth optical coupling unit OPT5 and the light emitting diode of the fifth optical coupling unit OPT6 are connected with the first processor 1 to acquire brain wave signals.
The anode of the light emitting diode of the second optical coupling unit OPT3, the anode of the light emitting diode of the third optical coupling unit OPT4, the anode of the light emitting diode of the fourth optical coupling unit OPT5 and the anode of the light emitting diode of the fifth optical coupling unit OPT6 are connected with a power supply; the control terminal K01, the control terminal K02, the control terminal K03 and the control terminal K04 are respectively connected with the pins 10, 9, 8 and 7 of the first processor 1.
The effect of the circuit is as follows: the pulse control circuit 4 generates a composite treatment electric shock signal to the composite electrode plate DJ01 and the composite electrode plate DJ02 according to the brain stimulation modulation wave signal and the brain wave signal; and the compound electrode plate DJ01 and the compound electrode plate DJ02 apply a compound treatment electric shock signal to the brain of the user to treat insomnia.
The electric shock direct current power supply comprises a boost controller circuit 41, wherein the direct current output end of the boost controller circuit 41 is connected with the other end of a resistor Q2R 1; the ground terminal of the boost controller circuit 41 is grounded. The dc power supply for electric shock is usually at a high voltage, such as 64V, to achieve a good electric shock effect, and the voltage of the battery power supply needs to be boosted by the boost controller circuit 41 to reach the voltage.
As shown in fig. 12, the boost controller circuit 41 adopts an MCP1650X boost controller, and a voltage input terminal of the MCP1650X boost controller is connected to a first dc 5V regulator chip U11.
With reference to fig. 13, the apparatus further includes a first power module, where the first power module supplies power to the first processor 1, the modulated wave generating module 3, and the pulse control circuit 4.
The first power module is provided with a first lithium battery, the first lithium battery is connected with a charging interface Header 5 through a first charging management controller U10, the first lithium battery is connected with a first boost type DC-DC converter U41, the first boost type DC-DC converter U41 is connected with a first direct current 5V voltage stabilizing chip U11 and outputs 5V direct current, and the first lithium battery is connected with a first direct current 3.3V output chip U21 and outputs 3.3V direct current.
As shown in fig. 15, the dashed line represents the user's brain wave signal, and the solid line represents the brain stimulation modulated wave signal.
Finally, it is noted that: the above-mentioned embodiments are only examples of the present invention, and it is a matter of course that those skilled in the art can make modifications and variations to the present invention, and it is considered that the present invention is protected by the modifications and variations if they are within the scope of the claims of the present invention and their equivalents.

Claims (10)

1. A control method of an insomnia therapeutic apparatus is used for the insomnia therapeutic apparatus, the insomnia therapeutic apparatus comprises a first processor (1), the first processor (1) is connected with a user brain wave acquisition module (2), and the first processor (1) acquires brain wave signals of a user through the user brain wave acquisition module (2);
the first processor (1) is also connected with a modulation wave generation module (3); the modulation wave generation module (3) stores brain stimulation modulation wave data; the first processor (1) is also provided with a signal output end group, and the first processor (1) is connected with the pulse control circuit (4) through the signal output end group; the pulse control circuit (4) is connected with a composite electrode plate unit (5);
the method is characterized by comprising the following steps:
step A: the first processor (1) collects the brain wave signals of the user through the brain wave acquisition module (2) of the user and judges the type of the brain wave signals of the user;
and B: the first processor (1) judges whether the type of the brain wave signal of the user belongs to a beta wave signal, and if so, the step C is carried out; otherwise, entering the step D;
and C: the first processor (1) generates a beta wave signal to the pulse control circuit (4), the pulse control circuit (4) superposes the beta wave signal on the brain stimulation modulation wave signal to generate a composite treatment electric shock signal a, and the composite treatment electric shock signal a is sent to the composite electrode plate unit (5); returning to the step A;
step D: the first processor (1) judges whether the brain wave signal type of the user belongs to an alpha wave signal, if so, the step E is carried out; otherwise, entering step F;
step E: the first processor (1) generates an alpha wave signal to the pulse control circuit (4), the pulse control circuit (4) superposes the alpha wave signal on the brain stimulation modulation wave signal to generate a composite treatment electric shock signal b, and the composite treatment electric shock signal b is sent to the composite electrode plate unit (5); returning to the step A;
step F: the first processor (1) judges whether the brain wave signal type of the user belongs to a theta wave signal, if so, the first processor (1) generates an alpha wave signal, superposes the theta wave signal in the same frequency domain and sends the theta wave signal to the pulse control circuit (4), and the pulse control circuit (4) superposes the alpha wave signal and the theta wave signal on the brain stimulation modulation wave signal to generate a composite treatment electric shock signal c which is sent to the composite electrode plate unit (5); returning to the step A; otherwise, entering step G;
step G: the first processor (1) judges whether the brain wave signal type of the user belongs to a delta wave signal, if so, the first processor (1) stops outputting signals to the pulse control circuit (4), and the step A is returned; otherwise, returning to the step A.
2. The method for controlling an insomnia therapeutic apparatus according to claim 1, wherein: the first processor (1) collects the brain wave signals of the user through the brain wave acquisition module (2), and the step of judging the types of the brain wave signals of the user comprises the following steps:
step A11: the first processor (1) collects the brain wave signals of a user through a user brain wave acquisition module (2);
step A12: the first processor (1) performs FFT frequency domain change on the brain wave signals;
step A13: the first processor (1) adopts an electroencephalogram acquisition algorithm to acquire the frequency f of the electroencephalogram signal of the user, the frequency of the electroencephalogram signal is represented by f, and the type of the electroencephalogram signal of the user is judged according to the frequency f of the electroencephalogram signal of the user.
3. The method for controlling an insomnia therapeutic apparatus according to claim 2, wherein: the judging the type of the brain wave signal of the user according to the brain wave signal frequency f of the user comprises:
if f is larger than 13Hz and f is less than or equal to 30Hz, judging that the brain wave signal of the user belongs to a beta wave signal;
if f is more than 8Hz and f is less than or equal to 13Hz, judging that the brain wave signal of the user belongs to an alpha wave signal;
if f is more than 4Hz and f is less than or equal to 8Hz, judging that the brain wave signal of the user belongs to the theta wave signal;
if f is more than or equal to 1Hz and f is less than or equal to 4Hz, the brain wave signal of the user is judged to belong to the delta wave signal.
4. The method for controlling an insomnia therapeutic apparatus according to claim 2, wherein: the electroencephalogram acquisition algorithm adopts a nonlinear dynamics method to calculate the sample entropy of the electroencephalogram signals of the user, and the frequency f of the electroencephalogram signals is obtained according to the sample entropy.
5. The method for controlling an insomnia therapeutic apparatus according to claim 1, wherein: the user brain wave acquisition module (2) comprises a second processor (21), the second processor (21) is in wired/wireless connection with the first processor (1), the second processor (21) is connected with an acquisition module (22), the acquisition module (22) is connected with an acquisition electrode plate (23) and/or a composite electrode plate unit (5), and the second processor (21) acquires brain wave signals of a user through the acquisition electrode plate (23) and/or the composite electrode plate unit (5).
6. The method for controlling an insomnia therapeutic apparatus according to claim 5, wherein: the acquisition module (22) is connected with the acquisition electrode plate (23) and the composite electrode plate unit (5) through an acquisition interface circuit; the composite electrode plate unit (5) comprises a composite electrode plate DJ01 and a composite electrode plate DJ 02;
the acquisition interface circuit comprises a first interface circuit and a second interface circuit, the first interface circuit comprises a capacitor C13, a capacitor C12, a capacitor C8 and a capacitor C9, and one end of the capacitor C13 is connected with a signal acquisition end AIN1_ P of the acquisition module (22); the other end of the capacitor C13 is grounded, and a signal acquisition end AIN1_ P is connected with the composite electrode plate DJ01 through a resistor R12;
one end of the capacitor C12 is connected with a signal acquisition end AIN1_ N of the acquisition module (22); the other end of the capacitor C12 is grounded, and one end of the capacitor C12 is also connected with one end of the resistor R11;
one end of the capacitor C9 is connected with a signal acquisition end AIN2_ P of the acquisition module (22); the other end of the capacitor C9 is grounded, and a signal acquisition end AIN2_ P is connected with the composite electrode plate DJ02 through a resistor R9;
one end of the capacitor C8 is connected with a signal acquisition end AIN2_ N of the acquisition module (22); the other end of the capacitor C8 is grounded, one end of the capacitor C8 is also connected with one end of the resistor R6, and one end of the resistor R6 is connected with the other end of the resistor R11;
the second interface circuit comprises a capacitor C2, one end of the capacitor C2 is connected with a signal acquisition end AIN3_ P of the acquisition module (22); the other end of the capacitor C2 is grounded, and the signal acquisition end AIN3_ P is connected with an acquisition electrode plate (23) through a resistor R3.
7. The method for controlling an insomnia therapeutic apparatus according to claim 1, wherein: the modulation wave generation module (3) comprises an analog signal generation module (31), and the analog signal generation module (31) is connected with a Flash memory (32) and an analog amplifier circuit (33); the first processor (1) is connected with the analog amplifier circuit (33) through the inverter circuit (34); the analog amplifier circuit (33) is connected with the pulse control circuit (4);
the Flash memory (31) stores brain stimulation modulation wave data; the analog signal generating module (32) acquires the brain stimulation modulation wave data of the Flash memory (31) to generate a brain stimulation analog electric wave signal to the analog amplifier circuit (33), and the analog amplifier circuit (33) outputs the brain stimulation modulation wave signal to the pulse control circuit (4).
8. The method for controlling an insomnia therapeutic apparatus according to claim 7, wherein: the first processor (1) is also connected with an analog amplifier circuit (33) through a digital potentiometer (35); the output signal of the analog amplifier circuit (33) is adjusted.
9. The method for controlling an insomnia therapeutic apparatus according to claim 1, wherein: the pulse control circuit (4) comprises a PNP triode Q2, a first optical coupling unit OPT1, a second optical coupling unit OPT3, a third optical coupling unit OPT4, a fourth optical coupling unit OPT5 and a fifth optical coupling unit OPT6, wherein an emitter of the PNP triode Q2 is connected with one end of a resistor Q2R1, the other end of the resistor Q2R1 is connected with an electric shock direct current power supply, the electric shock direct current power supply is further connected with a base electrode of the PNP triode Q2 through a resistor Q3R1, a collector electrode of a receiving triode of the first optical coupling unit OPT1 is connected with a base electrode of the PNP triode Q2, and an emitter electrode of the receiving triode of the first optical coupling unit OPT1 is grounded through a resistor Q3R 2; the light emitting diode of the first optical coupling unit OPT1 is connected with the analog amplifier circuit (33) to obtain a brain stimulation modulation wave signal;
a collector electrode of the PNP triode Q2 is connected with a collector electrode of the receiving triode of the second optocoupler unit OPT3, and a collector electrode of the receiving triode of the second optocoupler unit OPT3 is connected in parallel with a collector electrode of the receiving triode of the third optocoupler unit OPT 4; the composite electrode plate unit (5) comprises a composite electrode plate DJ01 and a composite electrode plate DJ 02; an emitter electrode of a receiving triode of the second optical coupling unit OPT3 is connected with the composite electrode plate DJ01, the composite electrode plate DJ01 is also connected with a collector electrode of a receiving triode of the fourth optical coupling unit OPT5, and an emitter electrode of the receiving triode of the fourth optical coupling unit OPT5 is grounded;
an emitter electrode of a receiving triode of the third optical coupling unit OPT4 is connected with the composite electrode plate DJ02, the composite electrode plate DJ02 is also connected with a collector electrode of a receiving triode of the fifth optical coupling unit OPT6, and an emitter electrode of the receiving triode of the fifth optical coupling unit OPT6 is grounded;
the light emitting diode of the second optical coupling unit OPT3, the light emitting diode of the third optical coupling unit OPT4, the light emitting diode of the fourth optical coupling unit OPT5 and the light emitting diode of the fifth optical coupling unit OPT6 are connected with the first processor (1) to acquire brain wave signals.
10. The method for controlling an insomnia therapeutic apparatus according to claim 9, wherein: the electric shock direct current power supply comprises a boost controller circuit (41), and the direct current output end of the boost controller circuit (41) is connected with the other end of the resistor Q2R 1; the ground terminal of the boost controller circuit (41) is grounded.
CN202011130700.4A 2020-10-21 2020-10-21 Control method of insomnia therapeutic apparatus Active CN112263767B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011130700.4A CN112263767B (en) 2020-10-21 2020-10-21 Control method of insomnia therapeutic apparatus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011130700.4A CN112263767B (en) 2020-10-21 2020-10-21 Control method of insomnia therapeutic apparatus

Publications (2)

Publication Number Publication Date
CN112263767A true CN112263767A (en) 2021-01-26
CN112263767B CN112263767B (en) 2023-03-21

Family

ID=74342974

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011130700.4A Active CN112263767B (en) 2020-10-21 2020-10-21 Control method of insomnia therapeutic apparatus

Country Status (1)

Country Link
CN (1) CN112263767B (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1166366A (en) * 1997-01-15 1997-12-03 唐健 Thinking and sleeping brain wave simulating equipment
JP2008100086A (en) * 2005-11-07 2008-05-01 Yasuo Chinen Electric stimulation system and method of low frequency therapeutical apparatus
CN107693944A (en) * 2017-10-23 2018-02-16 桂林宜康电子科技有限公司 A kind of sleep therapy instrument
CN110215592A (en) * 2019-04-30 2019-09-10 金脑元(武汉)医学生物科技有限公司 A kind of apparatus for curing insomnia based on brainwave feedback
CN111481799A (en) * 2019-01-28 2020-08-04 北京瑞博星航科技有限公司 Brain wave closed-loop control equipment

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1166366A (en) * 1997-01-15 1997-12-03 唐健 Thinking and sleeping brain wave simulating equipment
JP2008100086A (en) * 2005-11-07 2008-05-01 Yasuo Chinen Electric stimulation system and method of low frequency therapeutical apparatus
CN107693944A (en) * 2017-10-23 2018-02-16 桂林宜康电子科技有限公司 A kind of sleep therapy instrument
CN111481799A (en) * 2019-01-28 2020-08-04 北京瑞博星航科技有限公司 Brain wave closed-loop control equipment
CN110215592A (en) * 2019-04-30 2019-09-10 金脑元(武汉)医学生物科技有限公司 A kind of apparatus for curing insomnia based on brainwave feedback

Also Published As

Publication number Publication date
CN112263767B (en) 2023-03-21

Similar Documents

Publication Publication Date Title
CN101244314B (en) Electrostimulation platform system, method for setting therapy mode and storage medium
CN107596556B (en) Percutaneous vagus nerve stimulation system based on music real-time modulation
CN109793656A (en) A kind of portable ultraphonic physiotherapy equipment based on FUZZY ALGORITHMS FOR CONTROL
CN104189997A (en) Intelligent feedback high-potential therapeutic apparatus and therapeutic method
CN107693944A (en) A kind of sleep therapy instrument
CN103170058A (en) Electric needle system and electric needle and terminal controller thereof
CN111921089A (en) Self-adaptive adjustment vagus nerve stimulation system based on HRV parameter feedback
CN111939068A (en) Myoelectricity feedback intelligent acupuncture physiotherapy instrument
CN109603006B (en) Amplitude and phase controllable feedback electric stimulation platform based on specific frequency of brain electricity
Budgett et al. Novel technology for the provision of power to implantable physiological devices
CN113398470A (en) Nerve regulation and control system capable of enhancing sleep
CN108837304A (en) Regulator control system
CN112263767B (en) Control method of insomnia therapeutic apparatus
CN108853722A (en) A kind of control system of transcutaneous electrical stimulation physics headache therapeutic equipment
CN111013015A (en) Self-feedback physiotherapy instrument
CN113018683A (en) Transcranial real-time alternating current stimulation equipment and current control method
CN214435785U (en) Insomnia therapeutic instrument circuit
CN109224289A (en) Skin Nerve Stimulator Set
CN214074714U (en) Electroencephalogram composite electrode plate circuit for insomnia stimulation
CN213694062U (en) Earphone system with insomnia therapeutic instrument
CN214260314U (en) Sound stimulation and electric stimulation combined earphone
CN206837238U (en) A kind of transcranial magnetic stimulation excitation device based on Internet of Things
CN108543217A (en) A kind of apparatus for curing insomnia and Insomnia therapy method
CN209391934U (en) A kind of multifunctional basin bottom diagnosis governor circuit and multifunctional basin bottom diagnostic equipment
CN215387044U (en) Transcranial magnetic stimulation instrument with multiple physiological signal detection functions

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant